English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In November 1999 and August 2000, the Infectious Diseases Society of America Emerging Infections Network (EIN) surveyed its members about shortages of antimicrobial agents in their hospitals and medical centers. Almost 90% of the members had encountered shortages of 1 or more agents in 1999. Of 496 respondents, 382 (77%) reported diminished supplies of penicillin G. Other agents in short supply included meropenem (38%), ticarcillin with or without clavulanate (24%), cefazolin (20%), gentamicin (50%), and nafcillin-oxacillin (13%). In 2000, 291 (60%) of 485 respondents reported shortages of penicillin G, but significantly fewer members had experienced a lack of other agents. In both surveys, members indicated that shortages had affected numerous therapeutic indications. In 1999, members estimated that shortages had affected thousands of patients. In 2000, they estimated that fewer patients were affected. The results of these 2 EIN surveys raise questions about the forces that govern the availability of these valuable therapeutic resources.

National Shortages of Antimicrobial Agents: Results of 2 Surveys from the Infectious Diseases Society of America Emerging Infections Network